ArticleKidney international reports2019

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease.

Eric Lawitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.